Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


After the Cage Rage

This article was originally published in Start Up

Executive Summary

The long follow-up time in clinical trials and subjective endpoints of pain and quality of life continue to create market acceptance issues for new spinal surgery techniques. Cages are the latest example, as emerging long-term follow-up data bring into question their ability to enhance spinal fusion. Many believe artificial discs will eventually move orthopedics along the continuum from repair and restoration to replacement, but creating a physiologically active device capable of pumping water and waste, and determining which patients will benefit from it, is a formidable long-term challenge. In the meantime, minimally invasive spinal decompression procedures including vertebroplasty and kyphoplasty are gaining in popularity, as are, to some extent, radiofrequency techniques such as IDET. But here too, until multi-year follow-data from prospective trials are available, their use will also remain controversial.

Related Content


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts